Electroacupuncture alleviates neuropathic pain and long-term cognitive impairment via the rACC-vlPAG neural circuit.

Chronic pain doesn't just hurt—it can also affect your memory and thinking abilities. Researchers recently studied how electroacupuncture (EA), a form of acupuncture that uses mild electrical stimulation, might help both problems at once. Using rats with nerve injury-induced pain, scientists discovered that chronic pain changes activity in specific brain regions that control both pain processing and cognitive function. The study found that electroacupuncture at 2 Hz frequency significantly reduced both neuropathic pain and long-term cognitive problems in these animals. The researchers identified a particular brain circuit connecting the rostral anterior cingulate cortex (rACC) to the ventrolateral periaqueductal gray (vlPAG)—two regions involved in pain and cognition. They found that electroacupuncture works by calming down overactivity in this circuit. When this circuit was artificially blocked, pain and cognitive symptoms improved. When it was activated, the benefits of electroacupuncture were reversed. This suggests electroacupuncture produces measurable changes in brain activity that help explain why patients with chronic pain often report improvements in both pain levels and mental clarity after treatment. While this study was conducted in animals, it provides scientific support for what many acupuncture patients experience: relief from pain along with improved focus and memory. The findings help explain the biological mechanisms behind acupuncture's effects on the nervous system. If you're considering acupuncture for chronic pain or cognitive concerns, seek treatment from a licensed acupuncturist certified by the National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM).

This animal study investigated neural mechanisms underlying electroacupuncture's effects on comorbid neuropathic pain and cognitive dysfunction. Researchers used spared nerve injury (SNI) to induce neuropathic pain in rats, then employed fiber-optic calcium imaging and chemogenetic approaches to examine the rACC-vlPAG neural circuit. Key findings: 2 Hz EA significantly alleviated both chronic neuropathic pain and long-term cognitive impairments in SNI rats while increasing activity of CaMKII-positive neurons in the rACC. Chemogenetic inhibition of the rACC(CaMKII)-vlPAG circuit reduced pain and cognitive deficits, while activation negated EA's therapeutic effects. This suggests EA's mechanism involves downregulation of this specific neural pathway. The study provides neurobiological evidence for EA's dual action on pain and cognition, supporting clinical observations of concurrent improvements in both domains. The 2 Hz frequency specification offers practical guidance for treatment protocols addressing neuropathic pain with cognitive comorbidity. Further research is needed to translate these findings to human applications and optimize stimulation parameters.